Close Menu

NEW YORK (GenomeWeb) – Thermo Fisher Scientific and Cynvenio Biosystems have signed a distribution agreement for Cynvenio's LiquidBiopsy platform, the companies said today.

Cynvenio's LiquidBiopsy platform is designed to extract and isolate circulating tumor cells from a blood draw and prepare them for imaging and genomic analysis. According to Cynvenio's website, the platform uses a patented microfluidic chip to recover tumor cells from whole blood and can process up to four samples in under three hours.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A 50-year-old cold case was cracked using genetic genealogy, the New York Times reports.

NPR reports that some insect pests are now becoming resistant to Bt crops.

Science reports the US Food and Drug Administration did not consult an outside panel in its approval of remdesivir as a COVID-19 treatment.

In Nature this week: a framework for future human genomic research, PORE-cupine approach to study RNA structure using nanopore sequencing, and more.